Supplementary Table 4.docx (26.44 kB)

Supplementary Table 4. Nivolumab in gastric/gastroesophageal junction cancer: real-world data from UK Early Access to Medicines Scheme

dataset

posted on 2021-06-08, 08:34 authored by Mira Soni, Christopher Kiff, Robert Carroll, Dara Stein, Delphine Saragoussi, Ayman Nassar, Nick Maisey, David Tyas

Supplementary Table 4. Descriptive Summary of EQ-5D-3L at Baseline

Funding

Bristol-Myers Squibb

History

Usage metrics

Future Oncology

Keywords

ATTRACTION-2 CheckMate-032 Early Access to Medicines Scheme EQ-5D Gastric/gastrointestinal adenocarcinoma Health-related Quality of Life Medical records Nivolumab Real-world Solid Tumours

Licence

CC BY-NC-ND 4.0